BMYNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as CELG.RI
BRISTOL MYERS SQUIBB CO
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026
$58.83−0.92 (-1.54%)
Close on Oct 19, 2026
- Market cap
- $120.48B
- P/E (TTM)
- 13.0
- Dividend yield
- 4.23%
Dividends
Dividend declared per share by fiscal year, adjusted for stock splits
Per share, FY2025
$2.49
+2.9% on the prior year
Consecutive increases
15 years
Every year since FY2010
Dividend yield
4.23%
Latest annual dividend ÷ share price
Payout ratio, FY2025
71.5%
Dividends paid ÷ net income
Dividend history
By fiscal year
| Fiscal year | Per share | Change | Cash paid | Payout ratio |
|---|---|---|---|---|
| FY2025 | $2.49 | +2.9% | $5.05B | 71.5% |
| FY2024 | $2.42 | +4.8% | $4.86B | -54.3% |
| FY2023 | $2.31 | +5.5% | $4.74B | 59.1% |
| FY2022 | $2.19 | +9.0% | $4.63B | 73.2% |
| FY2021 | $2.01 | +9.2% | $4.40B | 62.9% |
| FY2020 | $1.84 | +9.5% | $4.08B | -45.2% |
| FY2019 | $1.68 | +4.3% | $2.68B | 77.9% |
| FY2018 | $1.61 | +2.5% | $2.61B | 53.1% |
| FY2017 | $1.57 | +2.6% | $2.58B | 255.9% |
| FY2016 | $1.53 | +2.7% | $2.55B | 57.1% |
| FY2015 | $1.49 | +2.8% | $2.48B | 158.3% |
| FY2014 | $1.45 | +2.8% | $2.40B | 119.7% |
| FY2013 | $1.41 | +2.9% | $2.31B | 90.1% |
| FY2012 | $1.37 | +3.0% | $2.29B | 116.6% |
| FY2011 | $1.33 | +3.1% | $2.25B | 60.8% |
Ex-dividend and payment dates for each distribution will appear once a dividend calendar source is connected.